Confirmation of the utility of the International Staging System and identification of a unique pattern of disease in Brazilian patients with multiple myeloma

Haematologica

Volumn 93, Issue 5, 2008, Pages 791-792

  Hungria, Vania T M ^a   Maiolino, Angelo ^b   Martinez, Gracia ^c   Colleoni, Gisele W B ^d   Coelho, Érika O D M ^e   Rocha, Laís ^f   Nunes, Renata ^g   Bittencourt, Rosane ^h   Oliveira, Luciana C O ^c   Faria, Rosa Malena O ⁱ   Pasquini, Ricardo ^j   Magalhães, Sílvia M M ^k   Souza, Cármino A ^l   Pinto Neto, Jorge V ^m   Barreto, Luciana ⁿ   Andrade, Elizabeth ^o   Portella, Maria Do Socorro O ^a   Bolejack, Vanessa ^p   Durie, Brian G M ^q  

^a Santa Casa de São Paulo ^*  (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^e HEMOPE   (Brazil)

^f FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^g HOSPITAL BRIGADEIRO   (Brazil)

^h FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

ⁱ FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^j FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^k FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^l UNIVERSITY OF CAMPINAS   (Brazil)

^m HOSPITAL DE BASE   (Brazil)

ⁿ INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^o Setor de Odontologia   (Brazil)

^p USA   (United States)

^q CEDARS SINAI MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; BRAZIL; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; FOLLOW UP; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; BRAZIL; DATABASES, FACTUAL; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; MULTIVARIATE ANALYSIS; MYELOMA PROTEINS; NEOPLASM STAGING; PROGNOSIS;

EID: 43449112388     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.11637     Document Type: Letter

References (6)

1. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol 2003;121:749-57.
2. Durie BG, Salmon SE. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer 1975;36:842-54.
3. Greipp PR, San Miguel J, Durie BG, Crowley JJ, Barlogie B, Bladé J, et al. International staging system for multiple myeloma. J Clin Oncol 2005;23:3412-20.
4. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
5. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-70.
6. Cox DR. Regression models and life tables (with discussion). J R Statist Soc 1972;34 (series B):187-220.